chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Alanine aminotransferase increased, Anion gap, Aspartate aminotransferase increased, Basophil percentage decreased
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium decreased, Blood chloride normal, Blood cholesterol normal
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine normal, Blood culture, Blood glucose normal, Blood lactic acid increased, Blood magnesium normal
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood phosphorus decreased, Blood potassium normal, Blood sodium decreased, Blood triglycerides normal, Blood urea increased
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, COVID-19 pneumonia, Carbon dioxide normal, Condition aggravated
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dehydration, Dyspnoea, Eosinophil percentage decreased, Fibrin D dimer
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Glomerular filtration rate, Glycosylated haemoglobin normal, HIV antibody negative, HIV antigen negative, Haematocrit increased
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin increased, Hepatic cirrhosis, Hepatitis A antibody positive, Hepatitis C antibody positive, Hepatitis C virus test positive
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: High density lipoprotein decreased, Hypertension, Hyponatraemia, Hypophagia, Immature granulocyte percentage increased
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Liver function test increased, Low density lipoprotein normal, Lymphocyte percentage decreased, Mean cell volume increased, Monocyte percentage
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Neutrophil count, Neutrophil percentage increased, Platelet count normal, Pyrexia, Red blood cell count normal
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell nucleated morphology, Red cell distribution width normal, SARS-CoV-2 test positive, White blood cell count decreased
Clinical narrative: 66 Y male with PMHx of HTN, GERD who presents with fever, cough, and shortness of breath x 10d. Pt admitted for COVID PNA and acute hypoxemic respiratory failure. See problem list below for details   # COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 9/8/21. COVID positive on 9/18/21. Last fever 100.4 on 9/21. Pt received the J&J vaccine on 9/4 per report. S/p 5 days of RDV. Of note, pt's wife is currently in the ICU for COVID PNA. Pt road tested, 2L O2 at rest and 4L NC with activity.  - Cont O2, wean with oxygen clinic (econsult placed) - Continue Decadron 6mg PO qday, finish 10 day course on 9/27 - End isolation on 9/29   # HTN: Pt stopped medication on his own years ago. He does not know his baseline blood pressure. Appears to previously have been on lisinopril 10mg qday in 2016.  - Continue lisinopril to 20mg po BID.    # Elevated LFTs: no abdominal pain. ?Covid related. Checked hepatitis panel. HCV screening test came back positive. No hx of liver disease or hep C in the chart. LFTs improved from admission. No clinical e/o cirrhosis.  - Per Dr. of GI. Repeat Hep C viral PCR in 1 month   # Elevated lactate: Lactate 2.8 in ED which may be due to poor po intake/dehydration (also slightly hyponatremic) vs Covid infection. No leukocytosis or fever. Given NS 500cc in ed. Lactate has cleared - F/u blood cultures (NGTD)   Primary Procedures:  None   Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis):  COVID PNA
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Hyperhidrosis
Clinical narrative: Patient received booster dose of Covid-19 Pfizer vaccine. Patient was observed in exit area for 15 minutes post vaccination with no complaints. As patient was exiting vaccine clinic, patient reported feeling sweaty and sat down on bench outside. Volunteer alerted public health nurse on site and nurse assessed patient. Patient was given bottled water and granola bar. She stated she felt better after water and snack, said she felt well enough to go home. Public health nurse advised patient to follow up with primary care doctor if she has any new symptoms. Patient was able to leave with daughter who brought her to the appointment.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Fatigue, Headache, Influenza like illness, Myalgia
Clinical narrative: Fatigue before going to bed.  I did not get good sleep that evening of the vaccine due to muscle soreness and joint pain.  I woke up with what felt like a full-blown flu with extreme fatigue, muscle soreness, systemic joint pain, a headache and sore throat.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Oropharyngeal pain
Clinical narrative: Fatigue before going to bed.  I did not get good sleep that evening of the vaccine due to muscle soreness and joint pain.  I woke up with what felt like a full-blown flu with extreme fatigue, muscle soreness, systemic joint pain, a headache and sore throat.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for COVID 8/29/21. ED visit and hospital admission 9/7/21 for COVID pneumonia.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Fibrosis, Hypotension, Rheumatoid nodule, Septic shock
Clinical narrative: Death SEPTIC SHOCK, HYPOTENSION, DIABETES MELLITUS TYPE 2, RHEUMATOID NODULAR FIBROSIS
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Type 2 diabetes mellitus
Clinical narrative: Death SEPTIC SHOCK, HYPOTENSION, DIABETES MELLITUS TYPE 2, RHEUMATOID NODULAR FIBROSIS
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Hypersensitivity, Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: Pt given vaccine and came back to the office about 4 hours later with a large painful, warm, red, itchy, swollen and hard lump at the injection site.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: Pt given vaccine and came back to the office about 4 hours later with a large painful, warm, red, itchy, swollen and hard lump at the injection site.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea
Clinical narrative: Patient started experiencing shortness of breath and chest tightness approximately 5 minutes after innoculation
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Dyspnoea, Fatigue, Gait disturbance
Clinical narrative: 9/28/21 9:a.m. till 2:00 p.m. - Rapid heart rate at 100 bpm (normal for me is 72 bpm) I felt like I was going to die. Heart rate was so high my blood pressure machine couldn't register my blood pressure or heart rate. 9/28/21 all day - Weak, difficult to walk 9/28/21 all day - Very tired 9/28/21 8 p.m. Short of breath Called my doctor in the morning when my heart was racing.  The nurse told me to rest and drink lots of fluids explaining this was a common reaction to the Covid vaccine.   9/29/21 8:00 a.m. feeling better, almost normal  but a bit tired.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Palpitations
Clinical narrative: 9/28/21 9:a.m. till 2:00 p.m. - Rapid heart rate at 100 bpm (normal for me is 72 bpm) I felt like I was going to die. Heart rate was so high my blood pressure machine couldn't register my blood pressure or heart rate. 9/28/21 all day - Weak, difficult to walk 9/28/21 all day - Very tired 9/28/21 8 p.m. Short of breath Called my doctor in the morning when my heart was racing.  The nurse told me to rest and drink lots of fluids explaining this was a common reaction to the Covid vaccine.   9/29/21 8:00 a.m. feeling better, almost normal  but a bit tired.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Feeling hot
Clinical narrative: I experienced a warm sensation, chest tightness and dizziness.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Pain
Clinical narrative: I've been having problems with the upper part of both my arms - right down to the muscle and joint. Any circular motion, lifting my arms, or moving my arms around is painful. It's difficult now to lift weights, weight train, or exercise with my arms.   I've been using ice packs, heat pads, Tylenol, and Motrin to deal with the pain.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: body aches, fatigue, headaches, sore arm
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstrual disorder
Clinical narrative: Patient has had 3 menstral cycles in 1 month following the covid vaccine. She has been regular up to the point of vaccination. This should be noted;
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray, Computerised tomogram thorax, Computerised tomogram thorax abnormal, Cough
Clinical narrative: Hospitalized 09/24/2021; COVID-19 positive 09/24/2021; fully vaccinated  HOSPITAL COURSE:     Patient is a 43 y.o. female  Comes from an AFC home Mother is guardian History is obtained from supervisor of AFC Home who is at bedside   It appears on the 19th, patient had onset of symptoms of fever, shortness of breath, cough Also recalls some diarrhea but denies any loss of taste or smell Self-medicated with Tylenol and Robitussin At that point, she was tested, results of which came back positive 9/21   She presented on 09/24 due to shortness of breath Was 92% on room air in the emergency department Chest x-ray obtained, patient was discharged on doxycycline She was referred to the monoclonal antibody clinic A she received monoclonal antibody 9/24   Upon returning to facility, patient appeared to be more short of breath Was found to be hypoxic, 87 on room air and febrile She was brought in for repeat evaluation.  CT angiogram thorax obtained. CT angiogram thorax negative for PE but did show a pneumonia In addition, she was requiring supplemental oxygen, received dexamethasone, ceftriaxone, doxycycline Subsequently admitted to Medicine. She was treated with Remdesevir and Decadron , and empirically with IV ceftriaxone and Doxycyline, her procal was low and there was no evidence of Secondary bacterial infection, antibiotics discontinued and she was successfully weaned of O2 , she remain afebrile while she is in the hospital . She was discharged in stable condition .
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Dyspnoea, Hypoxia, Pneumonia, Pyrexia
Clinical narrative: Hospitalized 09/24/2021; COVID-19 positive 09/24/2021; fully vaccinated  HOSPITAL COURSE:     Patient is a 43 y.o. female  Comes from an AFC home Mother is guardian History is obtained from supervisor of AFC Home who is at bedside   It appears on the 19th, patient had onset of symptoms of fever, shortness of breath, cough Also recalls some diarrhea but denies any loss of taste or smell Self-medicated with Tylenol and Robitussin At that point, she was tested, results of which came back positive 9/21   She presented on 09/24 due to shortness of breath Was 92% on room air in the emergency department Chest x-ray obtained, patient was discharged on doxycycline She was referred to the monoclonal antibody clinic A she received monoclonal antibody 9/24   Upon returning to facility, patient appeared to be more short of breath Was found to be hypoxic, 87 on room air and febrile She was brought in for repeat evaluation.  CT angiogram thorax obtained. CT angiogram thorax negative for PE but did show a pneumonia In addition, she was requiring supplemental oxygen, received dexamethasone, ceftriaxone, doxycycline Subsequently admitted to Medicine. She was treated with Remdesevir and Decadron , and empirically with IV ceftriaxone and Doxycyline, her procal was low and there was no evidence of Secondary bacterial infection, antibiotics discontinued and she was successfully weaned of O2 , she remain afebrile while she is in the hospital . She was discharged in stable condition .
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Hospitalized 09/24/2021; COVID-19 positive 09/24/2021; fully vaccinated  HOSPITAL COURSE:     Patient is a 43 y.o. female  Comes from an AFC home Mother is guardian History is obtained from supervisor of AFC Home who is at bedside   It appears on the 19th, patient had onset of symptoms of fever, shortness of breath, cough Also recalls some diarrhea but denies any loss of taste or smell Self-medicated with Tylenol and Robitussin At that point, she was tested, results of which came back positive 9/21   She presented on 09/24 due to shortness of breath Was 92% on room air in the emergency department Chest x-ray obtained, patient was discharged on doxycycline She was referred to the monoclonal antibody clinic A she received monoclonal antibody 9/24   Upon returning to facility, patient appeared to be more short of breath Was found to be hypoxic, 87 on room air and febrile She was brought in for repeat evaluation.  CT angiogram thorax obtained. CT angiogram thorax negative for PE but did show a pneumonia In addition, she was requiring supplemental oxygen, received dexamethasone, ceftriaxone, doxycycline Subsequently admitted to Medicine. She was treated with Remdesevir and Decadron , and empirically with IV ceftriaxone and Doxycyline, her procal was low and there was no evidence of Secondary bacterial infection, antibiotics discontinued and she was successfully weaned of O2 , she remain afebrile while she is in the hospital . She was discharged in stable condition .
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Ocular hyperaemia, Photophobia, Uveitis
Clinical narrative: Within hours of receiving the vaccine, patient reported severe eye pain, redness and photophobia. Diagnosed with uveitis/iritis and prescribed oral and topical steriods,  along with cycloplegics
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Ocular hyperaemia, Visual impairment
Clinical narrative: Within hours of receiving the vaccine, patient reported severe eye pain, redness and photophobia. Diagnosed with uveitis/iritis and prescribed oral and topical steriods,  along with cycloplegics
Age: 97.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood lactic acid increased, COVID-19, COVID-19 pneumonia, Cardiac failure
Clinical narrative: Admission Diagnoses: CAP (community acquired pneumonia) [J18.9] Community acquired pneumonia, unspecified laterality [J18.9]   Discharge Diagnoses:    Deceased Acute Hypoxic Respiratory Failure due to COVID 19 PNA   Hospital Course:  Patient is a 97-year-old female with a history of chronic atrial fibrillation, subdural hematoma, CAD status post CABG, CHF, hypertension, Waldenström's macroglobulinemia who presented for fever and cough.  The patient had a fever of 101 degrees for 2 days along with significant weakness and deconditioning.  She was fully vaccinated for COVID-19.  Upon arrival to the ER she was hemodynamically stable, T-max of 99.1 °F.  She had an admission evaluation which revealed WBC 8.8, elevated lactic acid 2.4.  She underwent a CT of the chest which showed no signs of pneumonia.  CT of the abdomen pelvis showed no evidence of obstruction and no acute abdominal abnormalities.  The patient was admitted under observation status due to generalized weakness.  Prior to transfer to the medical floor her viral PCR results were positive for COVID-19.  She was admitted under isolation status.  During the first few days of her hospitalization she did not have any respiratory symptoms and had significant deconditioning.  She did not meet criteria for remdesivir therapy.  Subsequently the patient had decompensation with hypoxia and respiratory failure requiring transfer to the ICU.  She was treated with steroids and remdesivir.  The patient had quick decompensation requiring BiPAP placement.  She had significant respiratory distress while on BiPAP and her family was consulted in regards to goals of care.  Due to her significant respiratory distress while on BiPAP the decision was made to make the patient comfort care.  The patient had comfort care medications administered along with removal of the BiPAP.  The patient passed away on September 28, 2021 at 7:34 AM.  Family was at the bedside.                 Consults: IP CONSULT  IP CONSULT TO SPIRITUAL CARE   Significant Diagnostic Studies: N/A   Discharge Exam: Blood pressure 96/56, pulse (!) 0, temperature 97.6 °F (36.4 °C), temperature source Temporal, resp. rate (!) 1, height 5' 1" (1.549 m), weight 49.4 kg (108 lb 14.4 oz), SpO2 93 %. Absent Pulses Absent Respirations Pupils fixed and Dilated   Disposition: Deceased   Code status: DNR   Time Spent on Discharge more than 30 minutes     Signed: MD 9/28/2021 10:33 AM
Age: 97.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram abdomen normal, Computerised tomogram thorax, Cough, Death, General physical health deterioration
Clinical narrative: Admission Diagnoses: CAP (community acquired pneumonia) [J18.9] Community acquired pneumonia, unspecified laterality [J18.9]   Discharge Diagnoses:    Deceased Acute Hypoxic Respiratory Failure due to COVID 19 PNA   Hospital Course:  Patient is a 97-year-old female with a history of chronic atrial fibrillation, subdural hematoma, CAD status post CABG, CHF, hypertension, Waldenström's macroglobulinemia who presented for fever and cough.  The patient had a fever of 101 degrees for 2 days along with significant weakness and deconditioning.  She was fully vaccinated for COVID-19.  Upon arrival to the ER she was hemodynamically stable, T-max of 99.1 °F.  She had an admission evaluation which revealed WBC 8.8, elevated lactic acid 2.4.  She underwent a CT of the chest which showed no signs of pneumonia.  CT of the abdomen pelvis showed no evidence of obstruction and no acute abdominal abnormalities.  The patient was admitted under observation status due to generalized weakness.  Prior to transfer to the medical floor her viral PCR results were positive for COVID-19.  She was admitted under isolation status.  During the first few days of her hospitalization she did not have any respiratory symptoms and had significant deconditioning.  She did not meet criteria for remdesivir therapy.  Subsequently the patient had decompensation with hypoxia and respiratory failure requiring transfer to the ICU.  She was treated with steroids and remdesivir.  The patient had quick decompensation requiring BiPAP placement.  She had significant respiratory distress while on BiPAP and her family was consulted in regards to goals of care.  Due to her significant respiratory distress while on BiPAP the decision was made to make the patient comfort care.  The patient had comfort care medications administered along with removal of the BiPAP.  The patient passed away on September 28, 2021 at 7:34 AM.  Family was at the bedside.                 Consults: IP CONSULT  IP CONSULT TO SPIRITUAL CARE   Significant Diagnostic Studies: N/A   Discharge Exam: Blood pressure 96/56, pulse (!) 0, temperature 97.6 °F (36.4 °C), temperature source Temporal, resp. rate (!) 1, height 5' 1" (1.549 m), weight 49.4 kg (108 lb 14.4 oz), SpO2 93 %. Absent Pulses Absent Respirations Pupils fixed and Dilated   Disposition: Deceased   Code status: DNR   Time Spent on Discharge more than 30 minutes     Signed: MD 9/28/2021 10:33 AM
Age: 97.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Intensive care, Physical deconditioning, Pneumonia, Positive airway pressure therapy
Clinical narrative: Admission Diagnoses: CAP (community acquired pneumonia) [J18.9] Community acquired pneumonia, unspecified laterality [J18.9]   Discharge Diagnoses:    Deceased Acute Hypoxic Respiratory Failure due to COVID 19 PNA   Hospital Course:  Patient is a 97-year-old female with a history of chronic atrial fibrillation, subdural hematoma, CAD status post CABG, CHF, hypertension, Waldenström's macroglobulinemia who presented for fever and cough.  The patient had a fever of 101 degrees for 2 days along with significant weakness and deconditioning.  She was fully vaccinated for COVID-19.  Upon arrival to the ER she was hemodynamically stable, T-max of 99.1 °F.  She had an admission evaluation which revealed WBC 8.8, elevated lactic acid 2.4.  She underwent a CT of the chest which showed no signs of pneumonia.  CT of the abdomen pelvis showed no evidence of obstruction and no acute abdominal abnormalities.  The patient was admitted under observation status due to generalized weakness.  Prior to transfer to the medical floor her viral PCR results were positive for COVID-19.  She was admitted under isolation status.  During the first few days of her hospitalization she did not have any respiratory symptoms and had significant deconditioning.  She did not meet criteria for remdesivir therapy.  Subsequently the patient had decompensation with hypoxia and respiratory failure requiring transfer to the ICU.  She was treated with steroids and remdesivir.  The patient had quick decompensation requiring BiPAP placement.  She had significant respiratory distress while on BiPAP and her family was consulted in regards to goals of care.  Due to her significant respiratory distress while on BiPAP the decision was made to make the patient comfort care.  The patient had comfort care medications administered along with removal of the BiPAP.  The patient passed away on September 28, 2021 at 7:34 AM.  Family was at the bedside.                 Consults: IP CONSULT  IP CONSULT TO SPIRITUAL CARE   Significant Diagnostic Studies: N/A   Discharge Exam: Blood pressure 96/56, pulse (!) 0, temperature 97.6 °F (36.4 °C), temperature source Temporal, resp. rate (!) 1, height 5' 1" (1.549 m), weight 49.4 kg (108 lb 14.4 oz), SpO2 93 %. Absent Pulses Absent Respirations Pupils fixed and Dilated   Disposition: Deceased   Code status: DNR   Time Spent on Discharge more than 30 minutes     Signed: MD 9/28/2021 10:33 AM
Age: 97.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulse absent, Pupil fixed, Pyrexia, Respiratory arrest, Respiratory distress
Clinical narrative: Admission Diagnoses: CAP (community acquired pneumonia) [J18.9] Community acquired pneumonia, unspecified laterality [J18.9]   Discharge Diagnoses:    Deceased Acute Hypoxic Respiratory Failure due to COVID 19 PNA   Hospital Course:  Patient is a 97-year-old female with a history of chronic atrial fibrillation, subdural hematoma, CAD status post CABG, CHF, hypertension, Waldenström's macroglobulinemia who presented for fever and cough.  The patient had a fever of 101 degrees for 2 days along with significant weakness and deconditioning.  She was fully vaccinated for COVID-19.  Upon arrival to the ER she was hemodynamically stable, T-max of 99.1 °F.  She had an admission evaluation which revealed WBC 8.8, elevated lactic acid 2.4.  She underwent a CT of the chest which showed no signs of pneumonia.  CT of the abdomen pelvis showed no evidence of obstruction and no acute abdominal abnormalities.  The patient was admitted under observation status due to generalized weakness.  Prior to transfer to the medical floor her viral PCR results were positive for COVID-19.  She was admitted under isolation status.  During the first few days of her hospitalization she did not have any respiratory symptoms and had significant deconditioning.  She did not meet criteria for remdesivir therapy.  Subsequently the patient had decompensation with hypoxia and respiratory failure requiring transfer to the ICU.  She was treated with steroids and remdesivir.  The patient had quick decompensation requiring BiPAP placement.  She had significant respiratory distress while on BiPAP and her family was consulted in regards to goals of care.  Due to her significant respiratory distress while on BiPAP the decision was made to make the patient comfort care.  The patient had comfort care medications administered along with removal of the BiPAP.  The patient passed away on September 28, 2021 at 7:34 AM.  Family was at the bedside.                 Consults: IP CONSULT  IP CONSULT TO SPIRITUAL CARE   Significant Diagnostic Studies: N/A   Discharge Exam: Blood pressure 96/56, pulse (!) 0, temperature 97.6 °F (36.4 °C), temperature source Temporal, resp. rate (!) 1, height 5' 1" (1.549 m), weight 49.4 kg (108 lb 14.4 oz), SpO2 93 %. Absent Pulses Absent Respirations Pupils fixed and Dilated   Disposition: Deceased   Code status: DNR   Time Spent on Discharge more than 30 minutes     Signed: MD 9/28/2021 10:33 AM
Age: 97.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, White blood cell count normal
Clinical narrative: Admission Diagnoses: CAP (community acquired pneumonia) [J18.9] Community acquired pneumonia, unspecified laterality [J18.9]   Discharge Diagnoses:    Deceased Acute Hypoxic Respiratory Failure due to COVID 19 PNA   Hospital Course:  Patient is a 97-year-old female with a history of chronic atrial fibrillation, subdural hematoma, CAD status post CABG, CHF, hypertension, Waldenström's macroglobulinemia who presented for fever and cough.  The patient had a fever of 101 degrees for 2 days along with significant weakness and deconditioning.  She was fully vaccinated for COVID-19.  Upon arrival to the ER she was hemodynamically stable, T-max of 99.1 °F.  She had an admission evaluation which revealed WBC 8.8, elevated lactic acid 2.4.  She underwent a CT of the chest which showed no signs of pneumonia.  CT of the abdomen pelvis showed no evidence of obstruction and no acute abdominal abnormalities.  The patient was admitted under observation status due to generalized weakness.  Prior to transfer to the medical floor her viral PCR results were positive for COVID-19.  She was admitted under isolation status.  During the first few days of her hospitalization she did not have any respiratory symptoms and had significant deconditioning.  She did not meet criteria for remdesivir therapy.  Subsequently the patient had decompensation with hypoxia and respiratory failure requiring transfer to the ICU.  She was treated with steroids and remdesivir.  The patient had quick decompensation requiring BiPAP placement.  She had significant respiratory distress while on BiPAP and her family was consulted in regards to goals of care.  Due to her significant respiratory distress while on BiPAP the decision was made to make the patient comfort care.  The patient had comfort care medications administered along with removal of the BiPAP.  The patient passed away on September 28, 2021 at 7:34 AM.  Family was at the bedside.                 Consults: IP CONSULT  IP CONSULT TO SPIRITUAL CARE   Significant Diagnostic Studies: N/A   Discharge Exam: Blood pressure 96/56, pulse (!) 0, temperature 97.6 °F (36.4 °C), temperature source Temporal, resp. rate (!) 1, height 5' 1" (1.549 m), weight 49.4 kg (108 lb 14.4 oz), SpO2 93 %. Absent Pulses Absent Respirations Pupils fixed and Dilated   Disposition: Deceased   Code status: DNR   Time Spent on Discharge more than 30 minutes     Signed: MD 9/28/2021 10:33 AM
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Computerised tomogram, Nephrolithiasis, Ultrasound scan
Clinical narrative: I was in so much pain - that was back that it started with. I went to Urgent Care and she sent me to Hospital for Cat Scan and Ultrasound and my insurance didn't cover them. And so I went into ER and they did a CAT Scan and they thought the kidney stone had passed because they didn't see it. They tested my stomach and started talking about my liver. Dr said he was pretty sure it was a kidney stone and it had passed already. It was a strong dose of medication and maybe it was small doses of Fentanyl at first and then maybe one big dose of Fentanyl lastly - and then they sent me home  but I kept throwing up  when I got home and I had to go back to ER. At the ER - they hydrated me and they gave me something to stop throwing up. On the safe side, they encouraged me to get Gall bladder checked- said I needed to get an ultrasound. I had that and they said my gall bladder was fine. But that first doctor was pretty sure that I had had  a kidney stone - and that it had passed. I do still have some back pain here and there but I am trying to be careful with what I am eating. I am trying to make sure I don't eat what causes kidney stones.   Immediate after the 2nd vaccine : 10:00PM of night chills and was freezing one night and that's just not me - I normally am hot.  That might have just been an overnight thing.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: I was in so much pain - that was back that it started with. I went to Urgent Care and she sent me to Hospital for Cat Scan and Ultrasound and my insurance didn't cover them. And so I went into ER and they did a CAT Scan and they thought the kidney stone had passed because they didn't see it. They tested my stomach and started talking about my liver. Dr said he was pretty sure it was a kidney stone and it had passed already. It was a strong dose of medication and maybe it was small doses of Fentanyl at first and then maybe one big dose of Fentanyl lastly - and then they sent me home  but I kept throwing up  when I got home and I had to go back to ER. At the ER - they hydrated me and they gave me something to stop throwing up. On the safe side, they encouraged me to get Gall bladder checked- said I needed to get an ultrasound. I had that and they said my gall bladder was fine. But that first doctor was pretty sure that I had had  a kidney stone - and that it had passed. I do still have some back pain here and there but I am trying to be careful with what I am eating. I am trying to make sure I don't eat what causes kidney stones.   Immediate after the 2nd vaccine : 10:00PM of night chills and was freezing one night and that's just not me - I normally am hot.  That might have just been an overnight thing.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Dyspnoea, Erythema, Fatigue
Clinical narrative: Leg blotching redness, severe stomach cramps, vomiting 24 hours more than 10 times, arm swelling redness and soreness, nausea, fatigue, shortness of breath, body aches, left side numbness, throat soreness, trouble walking, fever (hot to the touch), dizzy, loss of motor skills, irritable, mood swings, felt like I was dying.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Gait disturbance, Hypoaesthesia, Irritability, Mood swings
Clinical narrative: Leg blotching redness, severe stomach cramps, vomiting 24 hours more than 10 times, arm swelling redness and soreness, nausea, fatigue, shortness of breath, body aches, left side numbness, throat soreness, trouble walking, fever (hot to the touch), dizzy, loss of motor skills, irritable, mood swings, felt like I was dying.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: Leg blotching redness, severe stomach cramps, vomiting 24 hours more than 10 times, arm swelling redness and soreness, nausea, fatigue, shortness of breath, body aches, left side numbness, throat soreness, trouble walking, fever (hot to the touch), dizzy, loss of motor skills, irritable, mood swings, felt like I was dying.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Psychomotor skills impaired, Pyrexia, Rash macular, Vomiting
Clinical narrative: Leg blotching redness, severe stomach cramps, vomiting 24 hours more than 10 times, arm swelling redness and soreness, nausea, fatigue, shortness of breath, body aches, left side numbness, throat soreness, trouble walking, fever (hot to the touch), dizzy, loss of motor skills, irritable, mood swings, felt like I was dying.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cardiac monitoring, Chest X-ray, Chest discomfort, Dysphonia
Clinical narrative: Tightness in throat and change of voice (inability to project voice); tightness in chest; disrupted sleep patterns, jolted awake essentially every 2-3 hours every night with increased respiration rate, heart rate and lower than normal O2 levels. This has continued for 20 days.